Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Nessab's below 'job link' text certainly points to a single position in one of the listed locations.
"Ashfield Engage has partnered with Synairgen, an emerging respiratory biotech company, to hire an Associate Medical Affairs Director in the Respiratory Virology therapeutic area."
Based in London ...
"Inizio is a strategic partner for health and life sciences, that unites Ashfield and Huntsworth’s full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services."
https://inizio.health
Personally, whilst as confident as ever as to an eventual good outcome, I'm more than happy in the meantime to see any positive signs, yet more study publications promoting IFN, green shoots, blue moons or even smiling CEO's, just to keep going. Take it wherever you can get it.
Very interesting Spacman (although I don't pretend to understand the mechanics of all this) but thanks for sharing (and evidencing) your research. Hope you continue and we don't lose this level of input that we have sadly lost over the last 3 years from similarly well-informed posters who were not appreciated by all. Whether we agree or not, we are all guessing, so reasoned and evidenced opinions should be universally welcomed.
Seems like the war cry of 'Pandemic Preparedness' and a return to that area of concern that started its ascent on the COVID agenda nearly 3 years ago, may be making a much-needed comeback. Getting SNG001, as a novel therapeutic, into that ****nal would certainly be the light at the end of the now considerable tunnel we find ourselves in.
Still showing on SNG website, however...
"This job has expired on Recruit.net"
"Reasons could include the position has been filled or the company is not accepting new applicants."
https://www.recruit.net/job/lab-technician-jobs/0886432E3A8133A0
"The Secretariat is currently welcoming open nominations (closing 5th February) for STEG membership from scientists and experts in all regions with expertise in the areas critical to the success of the 100DM. The group will be selected by an independent selection panel and will ensure gender and regional diversity in addition to content area expertise."
With any potential CoI issues aside (that might de-bar any of the SNG team being actively seeking commercialisation), the fact that this was initiated during the UK's presidency in 2021, the inclusion of therapeutics as well as vaccines, the very specific, long-running expertise of the SNG's scientists into a broad spectrum, agnostic, novel therapeutic, one wonders if the likes of SSH or Prof Wilko would/could throw their hat in the ring for this time-limited role.
On considering the 'Swimming pool/Bathtub' analogy, in considering which way to go, I immediately thought (selfishly as to age) towards the relative timescales of the options and when tangible results could be realised for PI's. Of course this matters not to those making the decisions ... or does it? Getting SNG to where it needs to be is the goal but we all want to see it happen and bear the fruits. The world will not sit still (Brexit/Covid/Ukraine .. what's next?) So, where does a result sooner rather than later become a factor to ensure goal realisation, even if not the through the gold standard route that may have been the initial desire. Just musing ...
"A cutting-edge trial, testing whether a combination of anti-viral treatments can prevent people with COVID-19 from developing serious infections, has opened in Southampton."
"The trial is part of the AGILE drug testing platform, a UK-wide collaboration of research partners working to find potential new treatments for COVID-19 and fast-track them through early phase clinical trials."
https://www.southampton.ac.uk/ctu/news/2023/01/24-cutting-edge-covid-19-trial-opens-in-southampton.page
https://twitter.com/summitcopd5/status/1617492275474595840
"International Conference on COPD and Asthma
April 14-15, 2023 London, UK"
https://copd.annualcongress.com
"Join us in London, UK where the world’s leading basic scientists, clinical researchers, early-career investigators, clinicians, and the care research community will share breaking research discoveries that will lead to methods of prevention and treatment and improvements in COPD and Asthma."
"Track 11. Respiratory Tract Infections
Res?ir?t?ry Tr??t Infe?ti?ns ?re ?ny infe?ti?us dise?ses ?f the u??er ?nd l?wer res?ir?t?ry tr??t."
Oh dear ... and it was all going so well for 2023 ... back to school for some it seems and the playground is filling up.
I don't referee to any post in particular but we all lose out when the well-informed stop posting on here ... if we can keep it civilised maybe we will all benefit.
As we swim around the goldfish bowl endlessly searching the same space for something to grab hold of, whilst the water slowly drains away, we pontificate whether movement beyond the glass means something is coming to save us. Nothing is clear and it is far easier to believe nothing is happening than to consider logically, the greater likelihood (imho) that the very reason we are not being given new info or hints along the way is that the clever people are just too busy dealing with the clever stuff.
Nice post Spacman and just an example of yet another possible scenario no-one it appears had previously considered or at least mentioned ... maybe there are others, or negotiated hybrids. Just keep swimming I guess ...
If permitted to think out of the box relative to the wording of the advert, whilst not being tainted by 'norms', one might be tempted to think that (given the inclusion of regulators in SNG's list of regular contacts) some understanding may have been reached as to the collation of P2, A2P2/3 and P3 deep dive data, etc, which may have allowed SNG some fast track process reliant on inclusion on a (new) P3, whereby an EUA could be triggered in early course with sufficient corroborating (new) data, potentially before P3 conclusion. Thus, possibly making sense of the high degree of silence, the 'working at haste' comment, the new additional job positions, the PR push with conferences, podcasts and the Washington DC trio of talking heads , all designed to throw weight behind a novel process for a unique novel treatment?
All conjecture, or more likely just fantasy to try to reverse-engineer some meaning from just the latest advert ... then again, why not . Stranger things ... and all that.